This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 18 print issues and online access
$259.00 per year
only $14.39 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Data availability
The data that support the findings of this study are available from the corresponding author upon reasonable request.
References
Eyecee one preloaded and eyecee one crystal preloaded Intraocular lenses (Iols): stop using immediately and quarantine all preloaded eyecee one lenses DSI/2023/001. Available: https://www.gov.uk/ drug-device-alerts/eyecee-one-preloaded-and-eyecee-one-crystal- preloaded-intraocular-lenses-iols-stop-using-immediately-and- quarantine-all-preloaded-eyecee-one-lenses-dsi-slash-2023-slash- 001
Wang H, Jong JLZ, Chiu SJ, Kay WL, Tan JHY. Evaluation of raised intraocular pressure post EyeCee One preloaded intraocular lenses implantation. Eye. 2023;37:3293–4.
Jones RK, Jong JLZ, Ramjiani V, Tan JHY. EyeCee One preloaded intraocular lens: are patients with glaucoma more at risk? BMJ Open Ophthalmol. 2023;8:e001433.
NIDEK Updated FSN – updated urgent field safety notice. Medicines and healthcare products regulatory agency. Available: https://mhra-gov.filecamp.com/s/d/Obt8ldNjh8qP2HYC
Author information
Authors and Affiliations
Contributions
Osman Younus & Huda Al-Hayouti: Substantial contribution to acquisition, analysis, interpretation of data for the work. Drafting the work, revising it for critically important intellectual content. Final approval of version to be published. Accountable for all aspects of the work in ensuring questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Douglas Lyall. Revising the work for critically important intellectual content. Drafting the work. Final approval of version to be published.
Corresponding author
Ethics declarations
Competing interests
The authors have no conflict of interest to report. This manuscript has not previously been submitted for publication. None of the authors have any financial discs of interest to declare.
Ethics approval
This work formed part of a retrospective audit; the requirement for informed consent was thus waived.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Younus, O., Al-Hayouti, H. & Lyall, D. Management of treatment-resistant ocular hypertension post EyeCee one IOL implantation: an observational study. Eye (2024). https://doi.org/10.1038/s41433-024-03123-z
Received:
Revised:
Accepted:
Published:
DOI: https://doi.org/10.1038/s41433-024-03123-z